RESUMEN
To evaluate the effect of attendance to a non traditional day care center ("CADEL") on physical and psychomotor development, 366 children aged 2-5 years belonging to 22 centers were studied. Weight and height were measured at 0, 4 and 8 months and weight for age, height for age and weight for height indexes were calculated from WHO/NCHS standards. Psychomotor development at the beginning of the study and 8 months latter through a standard test (TEPSI) was evaluated. Mean weight and height monthly increments were 144 +/- 83 g and 0.54 +/- 0.16 cm, 72 and 90% respectively of normal growth. Protein energy malnutrition prevalence (30.8%) was not modified but subnormal values of psychomotor development (40.9%) decreased during the study (p less than 0.05 global, coordination and motor function). Language retardation did not improve with the attendance to the program. These centers represent low cost alternatives to extended coverage of preschool services for low income families. More active family integration and reinforcement of stimulation and educational activities may improve program effectiveness.
Asunto(s)
Desarrollo del Lenguaje , Programas Nacionales de Salud , Estado Nutricional , Desempeño Psicomotor , Guarderías Infantiles , Preescolar , Chile , Humanos , Evaluación de Programas y Proyectos de Salud , Muestreo , Factores SocioeconómicosAsunto(s)
Empleos en Salud , Fumar , Estudiantes de Medicina , Adolescente , Adulto , Factores de Edad , Chile , Femenino , Humanos , Masculino , Factores Sexuales , Tabaquismo/epidemiologíaAsunto(s)
Humanos , Masculino , Femenino , Estudiantes de Medicina , Nicotiana , Enfermeras y Enfermeros , Médicos , OdontólogosAsunto(s)
Recién Nacido , Poliomielitis/prevención & control , Vacuna Antipolio Oral , Vacunación , Chile , Femenino , Humanos , Esquemas de Inmunización , MasculinoAsunto(s)
Vacuna Antisarampión/administración & dosificación , Vacuna contra la Parotiditis/administración & dosificación , Vacuna contra la Rubéola/administración & dosificación , Vacunación , Formación de Anticuerpos , Niño , Preescolar , Chile , Humanos , Lactante , Sarampión/inmunología , Sarampión/prevención & control , Paperas/inmunología , Paperas/prevención & control , Rubéola (Sarampión Alemán)/inmunología , Rubéola (Sarampión Alemán)/prevención & control , Factores de Tiempo , Vacunación/efectos adversosAsunto(s)
Vacuna Antisarampión , Sarampión/prevención & control , Adolescente , Adulto , Niño , Chile , Estudios de Evaluación como Asunto , Humanos , VacunaciónAsunto(s)
Antiinfecciosos/uso terapéutico , Antagonistas del Ácido Fólico/uso terapéutico , Fiebre Paratifoidea/tratamiento farmacológico , Pirimidinas/uso terapéutico , Sulfametoxazol/uso terapéutico , Fiebre Tifoidea/tratamiento farmacológico , Adolescente , Adulto , Combinación de Medicamentos , Estudios de Evaluación como Asunto , Humanos , Masculino , Trimetoprim/uso terapéuticoAsunto(s)
Intoxicación por Arsénico , Contaminación del Agua , Preescolar , Chile , Humanos , Lactante , Masculino , Contaminación Química del AguaAsunto(s)
Vacuna Antisarampión , Sarampión/prevención & control , Adolescente , Niño , Preescolar , Chile , Femenino , Humanos , Lactante , Masculino , Sarampión/mortalidad , VacunaciónAsunto(s)
Vacuna contra Viruela , Viruela/prevención & control , Preescolar , Chile , Estudios de Evaluación como Asunto , Humanos , Inmunización , Lactante , VacunaciónAsunto(s)
Toxoide Tetánico , Tétanos/prevención & control , Chile , Humanos , Recién Nacido , Persona de Mediana Edad , VacunaciónAsunto(s)
Vacuna Antisarampión/inmunología , Anticuerpos Antivirales/sangre , Niño , Preescolar , Chile , Susceptibilidad a Enfermedades , Evaluación de Medicamentos , Humanos , Lactante , Sarampión/prevención & control , Vacuna Antisarampión/efectos adversos , Virus del Sarampión/inmunología , Vacunas Atenuadas/efectos adversos , Vacunas Atenuadas/inmunologíaAsunto(s)
Sarampión/prevención & control , Viruela/prevención & control , Vacunación , Preescolar , Chile , Femenino , Humanos , Lactante , Masculino , Vacuna Antisarampión , Métodos , Vacuna contra ViruelaRESUMEN
The results obtained in Chile after three years of vaccination with the Edmonston B strain of Enders attenuated vaccine have been reported. More than 620,000 children from eight months to five years of age - 54.7 per cent of the population in that age range - have been vaccinated. The serological studies reveal the persistence of serum antibodies for at least three years; good immunological response in underfed children; unsatisfactory serological response in infants under nine months of age. The total number of deaths in 1965 was the lowest registered in the last five years, and was 2,053 lower than in 1964. An epidemic occurred in the Province of Magallanes at the same time that vaccination was being carried out; this permitted demonstration of the high level of efficacy of the vaccine, through a comparison of the measles rates among vaccinated and among unvaccinated children. A 30-month follow-up of about 2,000 vaccinated and 2,000 unvaccinated children showed 12 cases of measles with one death in the vaccinated group, as against 340 cases with 24 deaths in the control group. An investigation of children hospitalized in Santiago was carried out during 1965. At that time 43 per cent of the city's population between eight months and five years of age had been vaccinated; 256 unvaccinated children were hospitalized with measles and there were 30 deaths, whereas only 5 vaccinated children
Asunto(s)
Sarampión/inmunología , Programas de Inmunización , ChileRESUMEN
The results obtained in Chile after three years of vaccination with the Edmonston B strain of Enders attenuated vaccine have been reported. More than 620,000 children from eight months to five years of age - 54.7 per cent of the population in that age range - have been vaccinated. The serological studies reveal the persistence of serum antibodies for at least three years; good immunological response in underfed children; unsatisfactory serological response in infants under nine months of age. The total number of deaths in 1965 was the lowest registered in the last five years, and was 2,053 lower than in 1964. An epidemic occurred in the Province of Magallanes at the same time that vaccination was being carried out; this permitted demonstration of the high level of efficacy of the vaccine, through a comparison of the measles rates among vaccinated and among unvaccinated children. A 30-month follow-up of about 2,000 vaccinated and 2,000 unvaccinated children showed 12 cases of measles with one death in the vaccinated group, as against 340 cases with 24 deaths in the control group. An investigation of children hospitalized in Santiago was carried out during 1965. At that time 43 per cent of the city's population between eight months and five years of age had been vaccinated; 256 unvaccinated children were hospitalized with measles and there were 30 deaths, whereas only 5 vaccinated children